Generation of an MHC class II based tumour vaccine in a murine breast carcinoma model
This study involved the conversion of class II MHC negative tumour cells, via transduction with the potent class II MHC transcription factor, Class II Transactivator (CIITA) to enhance in de novo expression of MHC class II molecules. CIITA-transfected tumour cells may act as surrogate antigen presen...
| Main Author: | |
|---|---|
| Published: |
University College London (University of London)
2011
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.625672 |